Search results for "molecular microbiology"

Accelerating drug discovery with better oligos

Moving quickly and safely through Phase I/IIa trials is critical to successful drug development.  The QPS Phase I research facilities feature more than 550 beds across six strategically located facilities on three continents. QPS is well known for its success in first-in-human clinical trials. All Phase I sites are staffed by expert clinical pharmacology teams that routinely conduct hundreds of phase I/IIa studies annually. 

With over 30 years of experience developing and manufacturing ELISAs and ligand binding assays for commercial use, Mercodia has a profound understanding of product lifecycle management. To ensure that the assays we develop for drug development are reliable, accurate, and precise, we have product development procedures in place that cover all phases of the lifecycle from design, development, and validation to routine use.